AbbVie, Inc. holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 70,243 | $14,717,313 | 0.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2025 |
| June 30, 2025 | 70,243 | $13,038,506 | 0.04% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2025 |
| Sept. 30, 2025 | 65,414 | $15,145,958 | 0.05% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Nov. 12, 2025 |
| Dec. 31, 2025 | 56,414 | $12,890,035 | 0.06% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 12, 2026 |
| March 31, 2026 | 45,542 | $9,904,930 | 0.06% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 14, 2026 |
| June 30, 2026 | 45,542 | $11,460,189 | 0.12% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Aug. 13, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.